Lung transplantation for COVID-19-associated ARDS
- PMID: 34224676
- PMCID: PMC8253542
- DOI: 10.1016/S2213-2600(21)00279-4
Lung transplantation for COVID-19-associated ARDS
Conflict of interest statement
JM received congress reimbursement fees from Fisher & Paykel and CSL Behring. MS received lectures fees from Xenios, Getinge, and Drager. All other authors declare no competing interests.
Comment in
-
Lung transplantation for COVID-19-associated ARDS - Authors' reply.Lancet Respir Med. 2021 Sep;9(9):e90. doi: 10.1016/S2213-2600(21)00288-5. Epub 2021 Jul 2. Lancet Respir Med. 2021. PMID: 34224678 Free PMC article. No abstract available.
Comment on
-
Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries.Lancet Respir Med. 2021 May;9(5):487-497. doi: 10.1016/S2213-2600(21)00077-1. Epub 2021 Mar 31. Lancet Respir Med. 2021. PMID: 33811829 Free PMC article.
References
-
- Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159–165. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical